Package 76045-114-10

Brand: naloxone hydrochloride

Generic: naloxone hydrochloride
NDC Package

Package Facts

Identity

Package NDC 76045-114-10
Digits Only 7604511410
Product NDC 76045-114
Product ID 76045-114_6503f42d-3303-497a-9653-4b6d89bf7833
Description

24 SYRINGE in 1 CARTON (76045-114-10) / 1 mL in 1 SYRINGE (76045-114-01)

Marketing

Marketing Status
Marketed Since 2024-04-02
Brand naloxone hydrochloride
Generic naloxone hydrochloride
Sample Package No

Linked Drug Pages (1)

Naloxone Hydrochloride ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAMUSCULAR", "INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "6503f42d-3303-497a-9653-4b6d89bf7833", "openfda": {"unii": ["F850569PQR"], "rxcui": ["1191250", "2679504"], "spl_set_id": ["201fdedf-1736-4e52-9d7d-de14292547fd"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "24 SYRINGE in 1 CARTON (76045-114-10)  / 1 mL in 1 SYRINGE (76045-114-01)", "package_ndc": "76045-114-10", "marketing_start_date": "20240402"}], "brand_name": "Naloxone Hydrochloride", "product_id": "76045-114_6503f42d-3303-497a-9653-4b6d89bf7833", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Opioid Antagonist [EPC]", "Opioid Antagonists [MoA]"], "product_ndc": "76045-114", "generic_name": "NALOXONE HYDROCHLORIDE", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Naloxone Hydrochloride", "active_ingredients": [{"name": "NALOXONE HYDROCHLORIDE", "strength": ".4 mg/mL"}], "application_number": "ANDA213573", "marketing_category": "ANDA", "marketing_start_date": "20240402", "listing_expiration_date": "20261231"}